{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:50:34Z","timestamp":1790772634677,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["NRF-NRFF2018-04"],"award-info":[{"award-number":["NRF-NRFF2018-04"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001475","name":"Nanyang Technological University","doi-asserted-by":"publisher","award":["NTU-ACE2021-07"],"award-info":[{"award-number":["NTU-ACE2021-07"]}],"id":[{"id":"10.13039\/501100001475","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canlet.2025.217727","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:24:12Z","timestamp":1744871052000},"page":"217727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["ATF4:p52 complex activates oncogenic enhancers in multiple myeloma via p300\/CBP recruitment to regulate BACH1"],"prefix":"10.1016","volume":"623","author":[{"given":"Daniel Aron","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8589-2938","authenticated-orcid":false,"given":"Nathan","family":"Harmston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-9466","authenticated-orcid":false,"given":"Yinghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"MAY","key":"10.1016\/j.canlet.2025.217727_bib1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3389\/fimmu.2019.01121","article-title":"Cell of origin and genetic alterations in the pathogenesis of multiple myeloma","volume":"10","author":"Barwick","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217727_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1178224219868235","article-title":"Multiple myeloma: an overview of management","volume":"13","author":"Bird","year":"2019","journal-title":"Palliative Care and Social Practice"},{"issue":"2","key":"10.1016\/j.canlet.2025.217727_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41408-021-00421-7","article-title":"Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma","volume":"11","author":"Jia","year":"2021","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.canlet.2025.217727_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/0008-5472.CAN-21-0921","article-title":"Super enhancer-mediated upregulation of HJURP promotes growth and survival of t(4;14)-positive multiple myeloma","volume":"82","author":"Jia","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217727_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-46728-4","article-title":"Aberrant non-canonical NF-\u03baB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma","volume":"15","author":"Ang","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2025.217727_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-\u03baB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.canlet.2025.217727_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the non-canonical NF-kB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib8","first-page":"1","article-title":"The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma","author":"Vo","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2025.217727_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6020059","article-title":"The NF-\u03baB activating pathways in multiple myeloma","volume":"6","author":"Roy","year":"2018","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.canlet.2025.217727_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"51","key":"10.1016\/j.canlet.2025.217727_bib11","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1038\/sj.onc.1209933","article-title":"Transcriptional regulation via the NF-\u03baB signaling module","volume":"25","author":"Hoffmann","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.canlet.2025.217727_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1006\/jmbi.1999.2823","article-title":"Characterization of the dimer interface of transcription factor NF\u03baB p50 homodimer","volume":"289","author":"Sengchanthalangsy","year":"1999","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217727_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","article-title":"Regulation of NF-\u03baB in autoimmunity","volume":"34","author":"Sun","year":"2013","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-023-04821-2","article-title":"NF-\u03baB\/p52 augments ETS1 binding genome-wide to promote glioma progression","volume":"6","author":"Sim","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.canlet.2025.217727_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.764164","article-title":"Origin of the functional distinctiveness of NF-\u03baB\/p52","volume":"9","author":"Ghosh","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217727_bib16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-18-2238","article-title":"YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma","volume":"79","author":"Han","year":"2019","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.canlet.2025.217727_bib17","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1074\/jbc.R000025200","article-title":"CREB-Binding protein and p300 in transcriptional regulation","volume":"276","author":"Vo","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.canlet.2025.217727_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001647","article-title":"Analysis of the RelA:CBP\/p300 interaction reveals its involvement in NF-\u03baB-Driven transcription","volume":"11","author":"Mukherjee","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.canlet.2025.217727_bib19","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.2147\/OTT.S205922","article-title":"Progress in the identification of gene mutations involved in multiple myeloma","volume":"12","author":"Hu","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"17","key":"10.1016\/j.canlet.2025.217727_bib20","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1182\/blood-2009-09-243535","article-title":"Classical and\/or alternative NF-\u03baB pathway activation in multiple myeloma","volume":"115","author":"Demchenko","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18632\/oncotarget.109","article-title":"A critical role for the NFkB pathway in multiple myeloma","volume":"1","author":"Demchenko","year":"2010","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18035-1","article-title":"ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation","volume":"11","author":"Bentsen","year":"2020","journal-title":"Nat. Commun."},{"issue":"6220","key":"10.1016\/j.canlet.2025.217727_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.canlet.2025.217727_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11071037","article-title":"AP-1 transcription factors as regulators of immune responses in cancer","volume":"11","author":"Atsaves","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/2643-3230.BCD-20-0183","article-title":"Translational activation of ATF4 through mitochondrial anaplerotic metabolic pathways is required for DLBCL growth and survival","volume":"3","author":"Li","year":"2022","journal-title":"Blood Cancer Discovery"},{"issue":"49","key":"10.1016\/j.canlet.2025.217727_bib26","doi-asserted-by":"crossref","first-page":"50829","DOI":"10.1074\/jbc.M409173200","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.canlet.2025.217727_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011014","article-title":"Genome-wide census of ATF4 binding sites and functional profiling of trait-associated genetic variants overlapping ATF4 binding motifs","volume":"19","author":"\u00d6rd","year":"2023","journal-title":"PLoS Genet."},{"issue":"9","key":"10.1016\/j.canlet.2025.217727_bib28","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1091\/mbc.E16-01-0039","article-title":"Transcription factor ATF4 directs basal and stress-induced gene expression in the unfolded protein response and cholesterol metabolism in the liver","volume":"27","author":"Fusakio","year":"2016","journal-title":"Mol. Biol. Cell"},{"issue":"6168","key":"10.1016\/j.canlet.2025.217727_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.canlet.2025.217727_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.699629","article-title":"Mcl-1 inhibition: managing malignancy in multiple myeloma","volume":"12","author":"Al-Odat","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.canlet.2025.217727_bib31","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1182\/bloodadvances.2021004469","article-title":"Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia","volume":"5","author":"Zhao","year":"2021","journal-title":"Blood Advances"},{"issue":"3","key":"10.1016\/j.canlet.2025.217727_bib32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.canlet.2025.217727_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tibs.2008.04.015","article-title":"A pervasive role of histone acetyltransferases and deacetylases in an NF-\u03baB-signaling code","volume":"33","author":"Calao","year":"2008","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/j.canlet.2025.217727_bib34","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.7150\/thno.73223","article-title":"Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"issue":"38","key":"10.1016\/j.canlet.2025.217727_bib35","doi-asserted-by":"crossref","first-page":"24088","DOI":"10.1074\/jbc.272.38.24088","article-title":"Characterization of human activating transcription factor 4, a transcriptional activator that interacts with multiple domains of cAMP-responsive element-binding protein (CREB)-binding protein (CBP)","volume":"272","author":"Liang","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.canlet.2025.217727_bib36","doi-asserted-by":"crossref","first-page":"41537","DOI":"10.1074\/jbc.M505294200","article-title":"p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain","volume":"280","author":"Lassot","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/j.canlet.2025.217727_bib37","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.399600","article-title":"ATF4-dependent regulation of the JMJD3 gene during amino acid deprivation can Be rescued in atf4-deficient cells by inhibition of deacetylation","volume":"287","author":"Shan","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-10518-z","article-title":"HDAC6 regulates NF-\u03baB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression","volume":"12","author":"Barter","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.canlet.2025.217727_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-021-00421-7","article-title":"Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma","volume":"11","author":"Jia","year":"2021","journal-title":"Blood Cancer J."},{"issue":"NOV","key":"10.1016\/j.canlet.2025.217727_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fonc.2018.00533","article-title":"Role and regulation of pro-survival BCL-2 proteins in multiple myeloma","volume":"8","author":"Slomp","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217727_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2013.02.017","article-title":"Control of autophagic cell death by caspase-10 in multiple myeloma","volume":"23","author":"Lamy","year":"2013","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.canlet.2025.217727_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101032","article-title":"The transcription factor BACH1 at the crossroads of cancer biology: from epithelial\u2013mesenchymal transition to ferroptosis","volume":"297","author":"Igarashi","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.canlet.2025.217727_bib43","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2017-09-808063","article-title":"Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma","volume":"131","author":"Jin","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.217727_bib44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2025.217727_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217727_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes & Diseases"},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","article-title":"The noncanonical NF-\u03baB pathway","volume":"246","author":"Sun","year":"2012","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.canlet.2025.217727_bib48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.celrep.2012.08.042","article-title":"The transcriptional specificity of NF-\u03baB dimers is coded within the \u03baB DNA response elements","volume":"2","author":"Wang","year":"2012","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.canlet.2025.217727_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217727_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107724","article-title":"The number of transcription factors at an enhancer determines switch-like gene expression","volume":"31","author":"Michida","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05644-0","article-title":"Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2025.217727_bib52","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1128\/MCB.16.5.2248","article-title":"A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit","volume":"16","author":"Lin","year":"1996","journal-title":"Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217727_bib53","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1073\/pnas.88.9.3720","article-title":"Cross-family dimerization of transcription factors Fos\/Jun and ATF\/CREB alters DNA binding specificity","volume":"88","author":"Hai","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12B","key":"10.1016\/j.canlet.2025.217727_bib54","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1101\/gad.3.12b.2083","article-title":"Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers","volume":"3","author":"Hai","year":"1989","journal-title":"Gene Dev."},{"issue":"9","key":"10.1016\/j.canlet.2025.217727_bib55","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1074\/jbc.RA119.012095","article-title":"Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C\/EBP\u03b2","volume":"295","author":"Ebert","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1074\/jbc.M005594200","article-title":"Crystal structure of the CCAAT box\/enhancer-binding protein \u03b2 activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA","volume":"276","author":"Podust","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12860-020-00296-9","article-title":"Differential contribution of p300 and CBP to regulatory element acetylation in mESCs","volume":"21","author":"Martire","year":"2020","journal-title":"BMC Molecular and Cell Biology"},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40364-024-00570-4","article-title":"Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy","volume":"12","author":"Hu","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2025.217727_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1347969","article-title":"Bach1: function, regulation, and involvement in disease","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.canlet.2025.217727_bib60","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCRESAHA.115.306829","article-title":"Bach1 represses wnt\/\u03b2-catenin signaling and angiogenesis","volume":"117","author":"Jiang","year":"2015","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.217727_bib61","doi-asserted-by":"crossref","first-page":"eaau7887","DOI":"10.1126\/sciadv.aau7887","article-title":"Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells","volume":"5","author":"Wei","year":"2019","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.canlet.2025.217727_bib62","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/nsmb.1516","article-title":"Bach1 inhibits oxidative stress\u2013induced cellular senescence by impeding p53 function on chromatin","volume":"15","author":"Dohi","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5327","key":"10.1016\/j.canlet.2025.217727_bib63","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1126\/science.277.5327.831","article-title":"Bypass of senescence after disruption of p21CIP1\/WAF1 gene in normal diploid human fibroblasts","volume":"277","author":"Brown","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.canlet.2025.217727_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/CCO.0b013e32835b639e","article-title":"P21WAF1 and tumourigenesis: 20 Years after","volume":"25","author":"Warfel","year":"2013","journal-title":"Curr. Opin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217727_bib65","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(95)90039-X","article-title":"Mice Lacking p21CIP1\/WAF1 undergo normal development, but are defective in G1 checkpoint control","volume":"82","author":"Deng","year":"1995","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.canlet.2025.217727_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.onc.1201529","article-title":"Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)","volume":"16","author":"Mandal","year":"1998","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.canlet.2025.217727_bib67","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217727_bib68","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-23-0954","article-title":"INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors","volume":"14","author":"Dietrich","year":"2024","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.canlet.2025.217727_bib69","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmet.2017.09.001","article-title":"ATF4-induced metabolic reprograming is a synthetic vulnerability of the p62-deficient tumor stroma","volume":"26","author":"Linares","year":"2017","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.canlet.2025.217727_bib70","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"XSuper-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.canlet.2025.217727_bib71","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","article-title":"Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma","volume":"24","author":"Chapuy","year":"2013","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.canlet.2025.217727_bib72","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.canlet.2025.217727_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.13","article-title":"Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients","volume":"4","author":"Walker","year":"2014","journal-title":"Blood Cancer J."},{"issue":"5","key":"10.1016\/j.canlet.2025.217727_bib74","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10565-021-09608-x","article-title":"Cooperation of ATF4 and CTCF promotes adipogenesis through transcriptional regulation","volume":"38","author":"Chen","year":"2022","journal-title":"Cell Biol. Toxicol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217727_bib75","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2025.217727_bib76","series-title":"General Spinfection Protocol","author":"Berggren","year":"2012"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:02:31Z","timestamp":1760742151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525002939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":76,"alternative-id":["S0304383525002939"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217727","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATF4:p52 complex activates oncogenic enhancers in multiple myeloma via p300\/CBP recruitment to regulate BACH1","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217727"}}